Quidel | QDEL - Operating Expenses


Quidel reported $646.2M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Abbott USD 10.46B 1.15B Jun/2026
Agilent USD 1.43B 2M Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Bruker USD 768.9M 44.3M Jun/2026
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 2.84B 1.96B Jun/2026
Danaher USD 52.58B 368M Jun/2026
Haemonetics USD 145.34M 148.66M Jun/2026
Illumina USD 899M 47M Jun/2026
IQVIA Holdings USD 1.77B 4.45B Jun/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Mettler Toledo International USD 739.77M 26.57M Jun/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Neogen USD 222.2M 7.7M Mar/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quidel USD 646.2M 1.21B Jun/2026
Revvity USD 603.55M 24.8M Jun/2026
STAAR Surgical USD 83.43M 7.32M Jun/2026
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
Waters USD 527M 592M Jun/2026